Petr Kaňovský Selected Research

Petr Kaňovský Research Topics

Disease

14	Stroke (Strokes) 06/2021 - 05/2011
7	Parkinson Disease (Parkinson's Disease) 01/2021 - 03/2012
6	Torticollis (Wryneck) 01/2021 - 07/2011
6	Ischemic Stroke 04/2020 - 08/2012
3	Cerebral Palsy (Spastic Diplegia) 01/2022 - 01/2015
3	Dystonia (Limb Dystonia) 01/2021 - 11/2011
3	Atrial Fibrillation 12/2018 - 01/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021 - 02/2016
2	Movement Disorders (Movement Disorder) 06/2021 - 01/2021
2	Muscle Spasticity (Spastic) 06/2021 - 01/2021
2	Optic Neuritis (Retrobulbar Neuritis) 12/2020 - 05/2018
2	Multiple Sclerosis 12/2020 - 05/2018
2	Cerebral Hemorrhage 04/2020 - 05/2018
2	Dementia (Dementias) 02/2016 - 08/2014
2	Paralysis (Palsy) 11/2014 - 08/2012
1	Amyloidosis 12/2021
1	Body Weight (Weight, Body) 10/2021
1	Pathologic Processes 01/2021
1	Pathologic Constriction (Stenosis) 12/2020
1	Essential Tremor (Essential Tremors) 09/2020
1	Obesity 09/2020
1	Camptocormia 01/2020
1	Tremor (Tremors) 01/2020
1	Spinal Cord Diseases 01/2018
1	Mental Disorders (Mental Disorder) 03/2016
1	Alzheimer Disease (Alzheimer's Disease) 02/2016
1	Multiple System Atrophy 02/2016
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2015
1	Hyperlipidemias (Hyperlipidemia) 12/2015
1	Brain Infarction 02/2015
1	Pain (Aches) 01/2015
1	Nervous System Diseases (Neurological Disorders) 01/2015
1	Sialorrhea 01/2015
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2015
1	Deglutition Disorders (Dysphagia) 01/2015
1	Muscle Weakness 01/2015
1	Blepharospasm 01/2015
1	Neck Pain (Cervicalgia) 01/2015
1	Blepharoptosis (Ptosis, Eyelid) 01/2015
1	Parkinsonian Disorders (Parkinsonism) 08/2014
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 09/2013
1	Disease Progression 03/2012
1	Diabetes Mellitus 01/2012
1	Hypertension (High Blood Pressure) 01/2012

Drug/Important Bio-Agent (IBA)

13	incobotulinumtoxinA FDA Link 01/2022 - 05/2011
13	Type A Botulinum Toxins (Botox)FDA Link 06/2021 - 05/2011
9	Botulinum Toxins (Botulinum Toxin)IBA 06/2021 - 07/2011
3	tau Proteins (tau Protein)IBA 12/2021 - 03/2012
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2012
2	Retinaldehyde (Retinal)IBA 12/2020 - 05/2018
2	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 04/2020 - 05/2018
2	Blood Glucose (Blood Sugar)IBA 12/2018 - 12/2015
2	ClusterinIBA 02/2016 - 08/2014
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 05/2011
1	Prion ProteinsIBA 12/2021
1	Protein Isoforms (Isoforms)IBA 12/2021
1	PrionsIBA 12/2021
1	Amyloid (Amyloid Fibrils)IBA 12/2021
1	Plant Growth Regulators (Plant Hormones)IBA 01/2021
1	CytokininsIBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	salsolinolIBA 01/2021
1	Apomorphine FDA Link 01/2020
1	Antihypertensive Agents (Antihypertensives)IBA 12/2018
1	Tryptophan (L-Tryptophan)FDA Link 03/2016
1	Biological ProductsIBA 03/2016
1	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2015
1	Troponin T (Troponin T1)IBA 02/2015
1	A 7 (A-7)IBA 11/2014
1	Chromogranin AIBA 11/2013
1	Levodopa (L Dopa)FDA LinkGeneric 03/2012
1	CholesterolIBA 01/2012
1	Triglycerides (Triacylglycerol)IBA 01/2012
1	NeurotoxinsIBA 05/2011

Therapy/Procedure

10	Therapeutics 06/2021 - 11/2011
5	Injections 10/2021 - 01/2015
2	Thrombectomy 04/2020 - 05/2018
2	Time-to-Treatment 12/2018 - 12/2015
1	Deep Brain Stimulation 09/2020
1	Decompression 01/2018
1	Stents 09/2013